Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Randomized Phase III Trial of ABVD Vs. Stanford V +/− Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)

Leo I Gordon, MD, FACP, Fanxing Hong, PhD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Henry Wagner, MD, Patrick J Stiff, MD, Bruce D. Cheson, MD, Mary Gospodarowicz, MD, FRCPC, Ranjana Advani, MD, Brad Kahl, MD, Jonathan W. Friedberg, MD, Kristie A. Blum, MD, Thomas M. Habermann, MD, Joseph Tuscano, Richard Hoppe, MD, Sandra J. Horning, MD

Blood (2010) 116 (21): 415.

https://doi.org/10.1182/blood.V116.21.415.415

Published: 2010

Journal Articles

Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496

Ranjana Advani, MD, Fangxin Hong, PhD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Sue Robinson, MD, Randy D. Gascoyne, MD, Henry Wagner, MD, Patrick J Stiff, MD, Bruce D. Cheson, MD, Douglas A. Stewart, MD, FRCP, Leo I Gordon, MD, FACP, Brad Kahl, MD, Jonathan W. Friedberg, MD, Kristie A. Blum, MD, Thomas M. Habermann, MD, Joseph Tuscano, MD, Richard Hoppe, MD, Sandra J. Horning, MD

Blood (2010) 116 (21): 416.

https://doi.org/10.1182/blood.V116.21.416.416

Published: 2010

Journal Articles

Chimerism and Tolerance after Combined Human Kidney and Hematopoietic Cell Transplantation Using Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin.

Robert Lowsky, MD, Judith Shizuru, MD, PhD, Stephan Busque, MD, John Scandling, MD, Minnie Sarwal, MD, Sussan Jones, Claudia Benike, Richard Hoppe, MD, Ed Engleman, MD, Sam Strober, MD

Blood (2008) 112 (11): 2174.

https://doi.org/10.1182/blood.V112.11.2174.2174

Published: 2008

Journal Articles

Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma: Clinical and Molecular Characterization of a Subset with Worse Outcome.

Denise Woo, MD, Chris Jones, MD, Monique Vanoli-Storz, MD, Sabine Kohler, MD, Sunil Reddy, MD, Ranjana Advani, MD, Richard Hoppe, MD, Youn Kim, MD

Blood (2007) 110 (11): 3573.

https://doi.org/10.1182/blood.V110.11.3573.3573

Published: 2007

Journal Articles

Bexarotene Is Highly Active in the Treatment of Subcutaneous Panniculitis-Like T-Cell Lymphoma.

Ana M. Molina, MD, Ranjana Advani, MD, Sunil Reddy, MD, Richard Hoppe, MD, Jonathan W. Friedberg, MD, Sara Sadan, MD, Patricia Myskowski, MD, Youn H. Kim, MD, Steven M. Horwitz, MD

Blood (2005) 106 (11): 3344.

https://doi.org/10.1182/blood.V106.11.3344.3344

Published: 2005

NARROW

A Randomized Phase III Trial of ABVD Vs. Stanford V +/− Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)

Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496

Chimerism and Tolerance after Combined Human Kidney and Hematopoietic Cell Transplantation Using Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin.

Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma: Clinical and Molecular Characterization of a Subset with Worse Outcome.

Bexarotene Is Highly Active in the Treatment of Subcutaneous Panniculitis-Like T-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

A Randomized Phase III Trial of ABVD Vs. Stanford V +/− Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)

Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496

Chimerism and Tolerance after Combined Human Kidney and Hematopoietic Cell Transplantation Using Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin.

Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma: Clinical and Molecular Characterization of a Subset with Worse Outcome.

Bexarotene Is Highly Active in the Treatment of Subcutaneous Panniculitis-Like T-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only